Skip to main content
Erschienen in: Osteoporosis International 5/2015

01.05.2015 | Original Article

Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012)

verfasst von: I. Etxebarria-Foronda, A. Arrospide, M. Soto-Gordoa, J. R. Caeiro, L. C. Abecia, J. Mar

Erschienen in: Osteoporosis International | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Summary

The objective is to analyse the evolution of the incidence of hip fracture in the female population of Spain from 2000 to 2012 and to establish the possible changes which may have been seen over this period of time, including the trends in the different regions of the country.

Introduction

Fragility-related hip fractures are considered to be the fractures of greatest significance to public health due to their high degree of morbidity and mortality. The change in their incidence, both in absolute values and when adjusted for age, is the subject of debate. The objective of this article is to describe the changes in the rates of hip fracture in Spain by autonomous community between the years 2000 and 2012.

Methods

Using the data from the Spanish Minimum Basic Data Set, in which are all the recorded cases of women with a principal diagnosis of hip fracture, the incidence rates by age group and by autonomous community were obtained. Poisson distribution or negative binomial regressions were carried out to estimate the average annual change over the time period analysed.

Results

There have been statistically significant changes in the trends of rates of incidence for all age groups of women over 65 years of age. The annual reduction was 2.2 % for women of 65–74 years of age and less for those between 75 and 84. The rates of incidence for those over 85 increased annually by 0.58 %.

Conclusions

Hip fractures continue to increase in absolute numbers, although if the rates are adjusted for age, a downward trend is seen in certain age groups. These findings have various origins, although in the absence of great changes in population structure, we believe that drug treatments for osteoporosis may play a role. There is variability in the change in incidence of hip fractures in different parts of the country. Further studies are required to be able to identify the causes.
Literatur
1.
Zurück zum Zitat Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475CrossRefPubMed Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475CrossRefPubMed
2.
Zurück zum Zitat Ivegard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Díez-Pérez A, Kanis JA (2013) Epidemiology and economic burden of osteoporosis in Spain. Arch Osteoporos 8(137):195–218 Ivegard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Díez-Pérez A, Kanis JA (2013) Epidemiology and economic burden of osteoporosis in Spain. Arch Osteoporos 8(137):195–218
3.
Zurück zum Zitat Auais M, Morin S, Nadeau L, Finch L, Mayo N (2013) Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada. Osteoporos Int 24:2713–2724CrossRefPubMed Auais M, Morin S, Nadeau L, Finch L, Mayo N (2013) Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada. Osteoporos Int 24:2713–2724CrossRefPubMed
4.
Zurück zum Zitat Hernández JL, Olmos JM, Alonso MA, González-Fernández CR, Martínez J, Pajarón M, Llorca J, González-Macías J (2006) Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int 17:464–470CrossRefPubMed Hernández JL, Olmos JM, Alonso MA, González-Fernández CR, Martínez J, Pajarón M, Llorca J, González-Macías J (2006) Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int 17:464–470CrossRefPubMed
5.
Zurück zum Zitat Leslie WD, O’Donell S, Jean S, Lagacé C, Walsh P, Bancej C, Morin S, Hanley DA, Papaoiannou A (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889CrossRefPubMed Leslie WD, O’Donell S, Jean S, Lagacé C, Walsh P, Bancej C, Morin S, Hanley DA, Papaoiannou A (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889CrossRefPubMed
6.
Zurück zum Zitat Fisher AA, O’Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of biphosphonates and hormone replacement therapy. Bone 45:246–253CrossRefPubMed Fisher AA, O’Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of biphosphonates and hormone replacement therapy. Bone 45:246–253CrossRefPubMed
7.
Zurück zum Zitat Chevalley T, Guilley E, Hermann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 40:1284–1289CrossRefPubMed Chevalley T, Guilley E, Hermann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 40:1284–1289CrossRefPubMed
8.
Zurück zum Zitat Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20:898–905CrossRefPubMed Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20:898–905CrossRefPubMed
9.
Zurück zum Zitat Azagra R, López-Expósito F, Martín-Sánchez JC, Aquyé A, Moreno N, Cooper C, Díez-Pérez A, Dennison EM (2014) Changing trends in the epidemiology of hip fractures in Spain. Osteoporos Int 25:1267–74CrossRefPubMed Azagra R, López-Expósito F, Martín-Sánchez JC, Aquyé A, Moreno N, Cooper C, Díez-Pérez A, Dennison EM (2014) Changing trends in the epidemiology of hip fractures in Spain. Osteoporos Int 25:1267–74CrossRefPubMed
10.
Zurück zum Zitat Etxebarria-Foronda I, Mar J, Arrospide A, Esnal-Baza E (2010) Trends in the incidence of hip fractures in women in the Basque country. Arch Osteoporos 5:131–137CrossRef Etxebarria-Foronda I, Mar J, Arrospide A, Esnal-Baza E (2010) Trends in the incidence of hip fractures in women in the Basque country. Arch Osteoporos 5:131–137CrossRef
11.
Zurück zum Zitat Melton LJ 3rd, Kanis JA, Johnell O (2005) Potential impact of osteoporosis treatment on hip fracture trends. J Bone Miner Res 20:895–897CrossRefPubMed Melton LJ 3rd, Kanis JA, Johnell O (2005) Potential impact of osteoporosis treatment on hip fracture trends. J Bone Miner Res 20:895–897CrossRefPubMed
12.
Zurück zum Zitat Abrahamsen B, Vestergaard P (2010) Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int 21:373–380CrossRefPubMed Abrahamsen B, Vestergaard P (2010) Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int 21:373–380CrossRefPubMed
13.
Zurück zum Zitat Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419CrossRefPubMed Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419CrossRefPubMed
14.
Zurück zum Zitat Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914–921CrossRefPubMed Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914–921CrossRefPubMed
15.
Zurück zum Zitat Bernal-Delgado E, García Armesto S, Peiró S (2014) Atlas VPM group. Atlas of variations in medical practice in Spain: the Spanish National Health Service under scrutiny. Health Policy 114:15–30CrossRefPubMed Bernal-Delgado E, García Armesto S, Peiró S (2014) Atlas VPM group. Atlas of variations in medical practice in Spain: the Spanish National Health Service under scrutiny. Health Policy 114:15–30CrossRefPubMed
16.
Zurück zum Zitat Cameron AC, Trivedi PK (1988) Regression analysis of count data. Cambridge University Press, Cambridge Cameron AC, Trivedi PK (1988) Regression analysis of count data. Cambridge University Press, Cambridge
17.
Zurück zum Zitat Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E, Chandran M, Borgström F (2011) Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 22:685–92CrossRefPubMed Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E, Chandran M, Borgström F (2011) Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 22:685–92CrossRefPubMed
18.
Zurück zum Zitat Richards M (2010) Extent and causes of international variations in drug usage. A report for the secretary of state for health by Professor Sir Mike Richards CBE. Central Office of Information, Londres Richards M (2010) Extent and causes of international variations in drug usage. A report for the secretary of state for health by Professor Sir Mike Richards CBE. Central Office of Information, Londres
19.
Zurück zum Zitat Guerra-García MM, Rodriguez-Fernández JB, Puga-Sarmiento E, Charle-Crespo MA, Gomes Carvalho CS, Prejigueiro-Santás A (2011) Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain. Aten Primaria 43:82–8CrossRefPubMed Guerra-García MM, Rodriguez-Fernández JB, Puga-Sarmiento E, Charle-Crespo MA, Gomes Carvalho CS, Prejigueiro-Santás A (2011) Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain. Aten Primaria 43:82–8CrossRefPubMed
20.
Zurück zum Zitat Briongos L, Sañudo S, García-Alonso M, Ruiz-Mambrilla M, Dueñas-Laita A, Pérez-Castrillón JL (2013) Treatment of osteoporosis and hip fractures in a Spanish health area. Eur Rev Med Pharmacol Sci 17:266–8PubMed Briongos L, Sañudo S, García-Alonso M, Ruiz-Mambrilla M, Dueñas-Laita A, Pérez-Castrillón JL (2013) Treatment of osteoporosis and hip fractures in a Spanish health area. Eur Rev Med Pharmacol Sci 17:266–8PubMed
21.
Zurück zum Zitat Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305CrossRefPubMed Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305CrossRefPubMed
22.
Zurück zum Zitat Imaz I, Zegarra P, González-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor biphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943–51CrossRefPubMed Imaz I, Zegarra P, González-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor biphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943–51CrossRefPubMed
23.
Zurück zum Zitat de Felipe R, Cáceres C, Cimas M, Dávila G, Fernández S, Ruiz T (2010) Clinical characteristics of patients under treatment for osteoporosis in a primary care centre. Who do we treat? Aten Primaria 42:559–63CrossRefPubMed de Felipe R, Cáceres C, Cimas M, Dávila G, Fernández S, Ruiz T (2010) Clinical characteristics of patients under treatment for osteoporosis in a primary care centre. Who do we treat? Aten Primaria 42:559–63CrossRefPubMed
24.
Zurück zum Zitat Lespessailles E, Cotté FE, Roux C, Fardellone P, Mercier F, Gaudin AF (2009) Incidence and features of osteoporosis in the French general population: the instant study. Joint Bone Spine 76:394–400CrossRefPubMed Lespessailles E, Cotté FE, Roux C, Fardellone P, Mercier F, Gaudin AF (2009) Incidence and features of osteoporosis in the French general population: the instant study. Joint Bone Spine 76:394–400CrossRefPubMed
25.
Zurück zum Zitat Cooper C, Eriksson JG, Forsén T, Osmond C, Tuomilehto J, Barker JP (2001) Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int 12:623–629CrossRefPubMed Cooper C, Eriksson JG, Forsén T, Osmond C, Tuomilehto J, Barker JP (2001) Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int 12:623–629CrossRefPubMed
26.
Zurück zum Zitat Alonso-Franch M, Redondo Del Río MP, Suárez-Cortina L (2010) Nutrition and bone health in children. An Pediatr (Barc) 72:80.e1–11CrossRef Alonso-Franch M, Redondo Del Río MP, Suárez-Cortina L (2010) Nutrition and bone health in children. An Pediatr (Barc) 72:80.e1–11CrossRef
27.
Zurück zum Zitat Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S–1086SPubMed Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S–1086SPubMed
28.
Zurück zum Zitat Arana-Arri E, Gutiérrez-Ibarlucea I, Ecenarro-Mugaguren A, Asua-Batarrita J (2007) Incidence of certain osteoporosis-determinig habits among post-menopausal women in the Basque country, Spain, in 2003. Rev Esp Salud Publica 81:647–656CrossRefPubMed Arana-Arri E, Gutiérrez-Ibarlucea I, Ecenarro-Mugaguren A, Asua-Batarrita J (2007) Incidence of certain osteoporosis-determinig habits among post-menopausal women in the Basque country, Spain, in 2003. Rev Esp Salud Publica 81:647–656CrossRefPubMed
29.
Zurück zum Zitat Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29CrossRefPubMedCentralPubMed Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162CrossRefPubMed Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162CrossRefPubMed
31.
Zurück zum Zitat Nichols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willet WC, Newcomb PA (2006) From menarche to menopause: trends among US women born from 1912 to 1969. Am J Epidemiol 164:1003–1011CrossRefPubMed Nichols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willet WC, Newcomb PA (2006) From menarche to menopause: trends among US women born from 1912 to 1969. Am J Epidemiol 164:1003–1011CrossRefPubMed
32.
Zurück zum Zitat Navarro-Valverde C, Quesada-Gómez JM (2014) Deficiencia de vitamina D en España. ¿Realidad o mito? Rev Osteoporos Metab Miner 6(Supl 1):S5–10CrossRef Navarro-Valverde C, Quesada-Gómez JM (2014) Deficiencia de vitamina D en España. ¿Realidad o mito? Rev Osteoporos Metab Miner 6(Supl 1):S5–10CrossRef
33.
Zurück zum Zitat García-Armesto S, Begoña Abadía-Taira M, Durán A, Hernández-Quevedo C, Bernal-Delgado E (2010) Spain: health system review. Health Syst Transit 12:1–295PubMed García-Armesto S, Begoña Abadía-Taira M, Durán A, Hernández-Quevedo C, Bernal-Delgado E (2010) Spain: health system review. Health Syst Transit 12:1–295PubMed
34.
Zurück zum Zitat Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M (2014) Multimorbidity patterns: a systematic review. J Clin Epidemiol 67:254–66CrossRefPubMed Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M (2014) Multimorbidity patterns: a systematic review. J Clin Epidemiol 67:254–66CrossRefPubMed
35.
Zurück zum Zitat Mar J, Arrospide A, Comas M (2010) Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model. Value Health 13:69–76CrossRefPubMed Mar J, Arrospide A, Comas M (2010) Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model. Value Health 13:69–76CrossRefPubMed
36.
Zurück zum Zitat Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin. Results from the national registry of atrial Fibrilation 2. Arch Intern Med 166:241–246CrossRefPubMed Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin. Results from the national registry of atrial Fibrilation 2. Arch Intern Med 166:241–246CrossRefPubMed
37.
Zurück zum Zitat Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59:781–786CrossRefPubMed Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59:781–786CrossRefPubMed
38.
Zurück zum Zitat Røste LS, Taubøll E (2007) Women and epilepsy: review and practical recommendations. Expert Rev Neurother 7:289–300CrossRefPubMed Røste LS, Taubøll E (2007) Women and epilepsy: review and practical recommendations. Expert Rev Neurother 7:289–300CrossRefPubMed
39.
Zurück zum Zitat Salomon DH, Cadarette SM, Choudhry NK, Canning C, Levin R, Stürmer T (2009) A cohort study of thiazolidinediones and fractures in older adults with diabetes. J Clin Endocrinol Metab 94:2792–2798CrossRef Salomon DH, Cadarette SM, Choudhry NK, Canning C, Levin R, Stürmer T (2009) A cohort study of thiazolidinediones and fractures in older adults with diabetes. J Clin Endocrinol Metab 94:2792–2798CrossRef
40.
Zurück zum Zitat Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE (2010) Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab 95:134–142CrossRefPubMed Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE (2010) Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab 95:134–142CrossRefPubMed
41.
Zurück zum Zitat Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953CrossRefPubMed Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953CrossRefPubMed
43.
Zurück zum Zitat Warriner AH, Mugavero MJ (2010) Bone changes and fracture risk in individuals infected with HIV. Curr Rheumatol Rep 12:163–169CrossRefPubMed Warriner AH, Mugavero MJ (2010) Bone changes and fracture risk in individuals infected with HIV. Curr Rheumatol Rep 12:163–169CrossRefPubMed
44.
Zurück zum Zitat Olmos JM, Valero C, Del Barrio AG, Amado JA, Hernández JL, Menéndez-Arango J, González-Macías J (2010) Time course of bone loss in patients with anorexia nerviosa. Int Eat Disord 43:537–542CrossRef Olmos JM, Valero C, Del Barrio AG, Amado JA, Hernández JL, Menéndez-Arango J, González-Macías J (2010) Time course of bone loss in patients with anorexia nerviosa. Int Eat Disord 43:537–542CrossRef
45.
Zurück zum Zitat Stein E, Ebeling P, Shane E (2007) Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 36:937–963CrossRefPubMed Stein E, Ebeling P, Shane E (2007) Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 36:937–963CrossRefPubMed
Metadaten
Titel
Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012)
verfasst von
I. Etxebarria-Foronda
A. Arrospide
M. Soto-Gordoa
J. R. Caeiro
L. C. Abecia
J. Mar
Publikationsdatum
01.05.2015
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 5/2015
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-3015-8

Weitere Artikel der Ausgabe 5/2015

Osteoporosis International 5/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.